ReviewDrug design, development and therapy2016

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors.

Shouta Miyatake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.